1. Breaking News: Celgene Stockholders Approve Proposed Acquisition by Bristol-Myers Squibb

    Breaking News:  Celgene Stockholders Approve Proposed Acquisition by Bristol-Myers Squibb

    SUMMIT, N.J.--(BUSINESS WIRE)--Apr 12, 2019--Celgene Corporation (NASDAQ: CELG) today announced that its stockholders have voted to approve the company’s proposed combination with Bristol-Myers Squibb Company (NYSE: BMY). Approximately 98% of the votes cast, and over 70% of the shares outstanding and entitled to vote, voted in favor of the transaction at the special meeting...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned